Trinity COVID-19 Immunology Project
The Trinity COVID-19 Immunology Project is a pioneering three-year research project which mobilises the expertise of Trinity’s world-leading immunologists and its frontline medical clinicians in St James’s Hospital to accelerate time-critical research to tackle the COVID-19 pandemic and to help prepare Ireland for future infectious disease epidemics.
Established in May 2020 with a foundational gift from AIB, the Trinity COVID-19 Immunology Project is accelerating research in four critical areas:
- Develop, validate and implement tests for SARS-CoV-2
- Investigate immune responses and disease pathogenesis in COVID-19 patients
- Design new therapeutics
- Inform vaccine design
The Trinity COVID-19 Immunology Project is led by Kingston Mills, Professor of Experimental Immunology and Director of Trinity Biomedical Sciences Institute (TBSI), and Aideen Long, Professor in Molecular Medicine and Director of Trinity Translational Medicine Institute (TTMI). It is a collaborative research project, led by TBSI and TTMI, and supported by the Clinical Research Facility based on the St. James’s Hospital campus.
TBSI houses the AIB COVID-19 Research Laboratories Hub and is home to the greatest critical mass of internationally recognised immunologists and scientists in Ireland, including Luke O’Neill FRS, Chair of Biochemistry and Cliona O'Farrelly, Chair in Comparative Immunology.
As well as the foundational support from AIB, the Trinity COVID-19 Immunology Project is supported by Science Foundation Ireland, corporate donors including Amundi, BWG Eurospar, Horizon Therapeutics, Kerry Group and Takeda, organisations including the Irish Lung Foundation and Dun Laoghaire Golf Club, and by individual donors.
COVID-19 Immunology Webinar
In this webinar facilitated by Bursar & Director of Strategic Innovation Professor Veronica Campbell, Kingston Mills, Aideen Long and Luke O’Neill will share their knowledge and discuss their research projects and their vision for how Trinity can leverage its expertise to control the COVID-19 epidemic in Ireland and contribute to the global effort to discover new drugs and vaccines.